EA201071119A1 - APPLICATION OF HETEROCYCLIC BENZO DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF ANXIETY DISORDERS - Google Patents

APPLICATION OF HETEROCYCLIC BENZO DERIVATIVES OF SULFAMIDE FOR THE TREATMENT OF ANXIETY DISORDERS

Info

Publication number
EA201071119A1
EA201071119A1 EA201071119A EA201071119A EA201071119A1 EA 201071119 A1 EA201071119 A1 EA 201071119A1 EA 201071119 A EA201071119 A EA 201071119A EA 201071119 A EA201071119 A EA 201071119A EA 201071119 A1 EA201071119 A1 EA 201071119A1
Authority
EA
Eurasian Patent Office
Prior art keywords
sulfamide
treatment
application
anxiety disorders
benzo derivatives
Prior art date
Application number
EA201071119A
Other languages
Russian (ru)
Other versions
EA019544B1 (en
Inventor
Вирджиния Л. Смит-Свинтоски
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA201071119A1 publication Critical patent/EA201071119A1/en
Publication of EA019544B1 publication Critical patent/EA019544B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Abstract

Изобретение представляет собой способ лечения тревожного расстройства и родственных патологических расстройств, включающий введение нуждающемуся в этом субъекту терапевтически эффективных количеств одного или более новых гетероциклических бензопроизводных сульфамида формулы (I) и формулы (II), как определяется настоящим документом. Настоящее изобретение направлено на создание способа лечения тревожного расстройства и родственных патологических расстройств, который включает введение монотерапии и в качестве варианта комбинированной терапии по крайней мере одним анксиолитиком.The invention is a method of treating anxiety disorder and related pathological disorders, comprising administering to a subject in need thereof a therapeutically effective amount of one or more new heterocyclic benzene derivatives of sulfamide of formula (I) and formula (II) as defined herein. The present invention is directed to a method for the treatment of anxiety disorder and related pathological disorders, which includes the introduction of monotherapy and as a combination therapy with at least one anxiolytic.

EA201071119A 2008-03-26 2008-03-26 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety EA019544B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2008/058210 WO2009120189A1 (en) 2008-03-26 2008-03-26 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety

Publications (2)

Publication Number Publication Date
EA201071119A1 true EA201071119A1 (en) 2011-06-30
EA019544B1 EA019544B1 (en) 2014-04-30

Family

ID=39926425

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201071119A EA019544B1 (en) 2008-03-26 2008-03-26 Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety

Country Status (8)

Country Link
EP (1) EP2276481B1 (en)
KR (1) KR101511574B1 (en)
AU (1) AU2008353489B2 (en)
BR (1) BRPI0822385A2 (en)
EA (1) EA019544B1 (en)
ES (1) ES2517598T3 (en)
UA (1) UA100552C2 (en)
WO (1) WO2009120189A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7662271B2 (en) * 2005-12-21 2010-02-16 Chevron U.S.A. Inc. Lubricating oil with high oxidation stability
US20070155824A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for disease modification / epileptogenesis
US8691867B2 (en) * 2005-12-19 2014-04-08 Janssen Pharmaceutica Nv Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction
US20070155827A1 (en) * 2005-12-19 2007-07-05 Smith-Swintosky Virginia L Use of benzo-fused heterocycle sulfamide derivatives for the treatment of depression

Also Published As

Publication number Publication date
EP2276481B1 (en) 2014-07-30
ES2517598T3 (en) 2014-11-03
EP2276481A1 (en) 2011-01-26
AU2008353489B2 (en) 2014-11-27
WO2009120189A1 (en) 2009-10-01
EA019544B1 (en) 2014-04-30
AU2008353489A1 (en) 2009-10-01
KR101511574B1 (en) 2015-04-15
UA100552C2 (en) 2013-01-10
KR20100134052A (en) 2010-12-22
BRPI0822385A2 (en) 2019-09-24

Similar Documents

Publication Publication Date Title
EA201000603A1 (en) APPLICATION OF ANTIBODIES TO TRKB FOR THE TREATMENT OF RESPIRATORY DISTURBANCES
EA201170349A1 (en) MIF MODULATORS
EA201071264A1 (en) AMINODIGIDROTIAZINE DERIVATIVES AS BACE INHIBITORS FOR THE TREATMENT OF ALCHEIMER'S DISEASE
EA201000673A1 (en) METHODS AND COMPOSITIONS FOR MEASURING THE ACTIVATION OF Wnt AND FOR TREATING Wnt-MEDIATED CANCER DISEASES
EA201370208A1 (en) RIFAXIMINE FORMS AND THEIR APPLICATION
EA201071089A1 (en) HINAZOLIN DERIVATIVES AS RAF-KINASE MODULATORS AND METHODS FOR THEIR APPLICATION
EA200801897A1 (en) MNK2 inhibitors based on 8-heteroarylpurine for the treatment of metabolic disorders
EA201071245A1 (en) NEW THERAPEUTIC APPROACHES FOR THE TREATMENT OF ALZGEYMER'S DISEASE AND RELATED DISTURBANCES THROUGH MODULATION OF THE STRESS RESPONSE
EA201791669A3 (en) NEW THERAPEUTIC APPROACHES IN THE TREATMENT OF SMT AND RELATED DISORDERS
EA200801551A1 (en) USE OF SULPHONAMIDE DERIVATIVES IN THE TREATMENT OF METABOLISM AND NERVOUS SYSTEM DISORDERS
EA200901212A1 (en) 3-IMIDAZOLYLINDOLES INTENDED FOR THE TREATMENT OF PROLIFERATIVE DISEASES
EA201000046A1 (en) SUBSTITUTED IMIDASOGETEROCYCLES
EA201000428A1 (en) OXADIAZOLE AND OXIA-SUBSTITUTED DERIVATIVES OF BENZIMIDAZOLE AND INDOL AS INHIBITORS DGAT1
EA201390711A1 (en) HYDROXYAMIDE COMPOUNDS OF Pyrimidine As Inhibitors of Protein Deacetylases and Methods for Their Use
EA201071243A1 (en) COMBINED COMPOSITIONS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND RELATED DISEASES WITH ZONISSMID AND ACAPROSAT
EA201000016A1 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER, TUMORS AND DISTURBANCES ASSOCIATED WITH TUMORS
EA201001647A1 (en) DERIVATIVES OF BENZOFURANE, BENZOTHIOPHENE, BENZOTHIAZOLE AS A FXR MODULATORS
ATE478072T1 (en) SPIROIMIDAZOLE DERIVATIVES AS PPAR MODULATORS
EA201000895A1 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF LIZOSOME DISEASES
EA200970946A1 (en) COMBINED THERAPY OF ANTI-COAGLING AGENT WITH CONNECTION THAT WORKS AS AN INHIBITOR OF XA
EA201100750A1 (en) SUBSTITUTED DIOXOPIPERIDINYL-PHTHALIMIDE DERIVATIVES
MX2010002732A (en) F1f0-atpase inhibitors and related methods.
EA201071038A1 (en) DERIVATIVES 1-BENZYL-3-HYDROXYMETHYLINDASOL AND THEIR APPLICATION FOR THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 AND P40
EA201101686A1 (en) NEW COMPOSITIONS FOR THE TREATMENT OF CMT AND RELATED DISORDERS
EA200971141A1 (en) COMPOUNDS ACTIVATING TELOMERASE AND METHODS OF THEIR APPLICATION

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU